Font Size: a A A
Keyword [CD19]
Result: 141 - 160 | Page: 8 of 9
141. HMGB1 C106A Mutation Inhibits The Proliferation Of CD19hiFcγRⅡBhiB Cells And Related Mechanisms
142. CD19/22 CAR T Cell Cocktail Therapy For B-ALL Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation
143. Correlation Between Expression Of T Cell Subsets,B Cells,NK Cells And Clinical Activity In ITP Patients
144. The Effect Of C-Jun Overexpression On The Function Of Cord Blood Derived CD19.CAR-T Cells
145. 1. The Role Of CD19 Epitope Deletion In BiTE Therapy For Immune Escape. 2. The Role Of The Combined Effect Of NPM1 Mutation And IDH1 Mutation In The Development Of AML
146. Optimization Of CD19 CAR-T Based On CXCL12/CXCR4 To Enhance The Anti-tumor Effect In Lymphoma
147. Study The Efficacy Of ITK Gene-Edited CD19 CAR T Cells On Chronic Lymphocytic Leukemia
148. The Efficacy And Safety Study Of CD19 CAR-T Cells Immunotherapy For Relapse/Refractory Diffuse Large B-cell Lymphoma Patients—A Single Center,Single Arm,Open Clinical Study
149. The Clinical And Mechanistic Study Of Synergistic Combination Of IFN-α With CD19/CD22 Bispecific Targeted CAR-T Cell Therapy In Relapsed And Refractory Bcell Acute Lymphoblastic Leukemia
150. Role Of Leukemia-derived Extracellular Vesicles In CD19 CAR-T Cell Exhaustion
151. Extracellular Vesicles Armed With Target Antigen Or Cytokines Drive Efficacy Of Chimeric Antigen Receptor-T Cells
152. Study On Generation Of Cord Blood-derived CD19-CAR T Cells And The Anti-tumor Effects In Diffuse Large B-cell Lymphoma
153. Study On The Mechanism Of Human-derived CD19 CAR-T Cell Therapy In Rescuing Relapsed/Refractory Diffuse Large B-cell Lymphoma Unresponsive To Mouse-derived CD19 CAR-T Cell Therapy
154. The Regulatory Roles Of MicroRNA In Patients With Immune Thrombocytopenia
155. Preparation Of Anti-CD19 RAAV-CAR-T Cells For Cancer Immunotherapy
156. Study On The Effect And Mechanism Of Qiyin Sanliangsan In Assisting CD19 CAR-T Cells In The Treatment Of B-cell Lymphom
157. Efficacy And Safety Of CAR-T Cell Therapy In Patients With Central Nervous System Lymphoma
158. Research On Anti-tumor Effect And Mechanism Of Nanobody-based CD 19 CAR T Cells With PD-1 Secretion
159. Mechanism Of Targeting Glutamine To Regulate Glucose Metabolism Reprogramming And Overcome Immune Escape Of CD19 CAR-T Cells In The Treatment Of Acute Lymphoblastic Leukemia
160. Efficacy And Safety Of Anti-CD19/CD22 Chimeric Antigen Receptor T Cells In The Treatment Of Relapsed And Refractory Acute B Lymphoblastic Leukemia
  <<First  <Prev  Next>  Last>>  Jump to